Market Research Logo

Epilepsy: Selections from "The World Market for Neurotherapeutic Drugs"

This report on epilepsy represents selections from the larger market research study on neurotherapeutic drugs published by Kalorama Information in August 2002. The full study looked at the entire range of non-psychiatric neurological diseases and their treatments in the top seven world health markets. Here we present those parts of that study that are germane to epilepsy.

In addition to the selections relevant to epilepsy, we have also included the following from the full study in this report:

  • The complete Executive Summary from the full study;
  • Discussion of promising cutting-edge technologies and treatments with potentially broad application not limited to epilepsy;
  • Top-level market numbers on the total worldwide market for neurotherapeutic drugs;
  • The Conclusions and Strategic Implications from the full study;
  • Appendix A: Glossary of Terms; and
  • Appendix B: Company Directory


Executive Summary

  • Background
  • Scope and Methodology
  • Size and Growth of Market
  • Market Trends

Overview of Neurologic Diseases and Disorders

    Background
    • History
    • Neurologic Examination
    • Diagnostic Procedures

    Pathophysiology

    • Peripheral Nerve and Skeletal Muscle Diseases and Disorders
    • Central Nervous System Diseases and Disorders

    Key Neurologic Diseases and Disorders

    • Epilepsy

Treatment of Neurologic Diseases and Disorders

    Epilepsy
    • Pharmacologic Approaches
    • Surgical Approaches

Progress and Promise in Therapeutics Development

    Genetics and Neurogenomics

    Neural Implant Technologies

    Miscellaneous Advances

    • Vascular Endothelial Growth Factor (VEGF)
    • Minocycline
    • Stroke and Apoptosis

    Clinical Trial Activity

World Market Analysis

    Background

    The Markets by Geography

    • The United States
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Japan

    The Market by Applications

    • Epilepsy

Company Profiles

  • Cephalon, Inc.
  • Cognetix Incorporated
  • Diacrin
  • D-Pharm Ltd.
  • Elan Corporation plc
  • NeoTherapeutics, Inc.
  • NPS Pharmaceuticals, Inc.
  • Neurochem, Inc.
  • Shire Pharmaceuticals Group plc

Conclusions and Strategic Implications

  • First Conclusion
  • Second Conclusion
  • Third Conclusion
  • Fourth Conclusion
  • Fifth Conclusion
  • Sixth Conclusion
  • Seventh Conclusion

Glossary

Company Directory

List of Exhibits

  • Table 1-1: Estimated Market Sizes for the Top Five Applications Segments for Neurotherapeutics in the Major World Healthcare Markets, 2001-2009
  • Table 1-2: Estimated Market Sizes for the Geographic Segments for Neurotherapeutics in the Major World Healthcare Markets, 2001-2009
  • Table 2-1: Neurologic Diseases and Disorders as Classified by the United States National Institute of Neurological Disorders and Stroke 2002
  • Table 2-2: Classification of Diseases and Disorders of Peripheral Nerve and Skeletal Muscle
  • Table 2-3: Classification of Diseases and Disorders of the Central Nervous System
  • Table 3-4: Commonly Used Epilepsy Drugs
  • Table 3-5: Major Antiviral Drugs Used to Treat Central Nervous System Infections
  • Table 3-6: Antiretroviral Drugs
  • Table 3-7: Therapies for Key Neurologic Cancers
  • Table 4-1: Known Genetic Alternation in Neurologic Neoplasms
  • Table 4-6: Active Clinical Trials Involving Epilepsy
  • Table 5-1: The Potential for Neurotherapeutics in the Seven Major World Healthcare Markets, 2001-2010
  • Table 5-2: The Potential for Neurotherapeutics in the United States by Application, 2001-2010
  • Table 5-3: The Potential for Neurotherapeutics in France by Application, 2001-2010
  • Table 5-4: The Potential for Neurotherapeutics in Germany by Application, 2001-2010
  • Table 5-5: The Potential for Neurotherapeutics in Italy by Application, 2001-2010
  • Table 5-6: The Potential for Neurotherapeutics in Spain by Application, 2001-2010
  • Table 5-7: The Potential for Neurotherapeutics in the United Kingdom by Application, 2001-2010
  • Table 5-8: The Potential for Neurotherapeutics in Japan by Application, 2001-2010
  • Table 5-9: The Potential for Neurotherapeutics in the Major World Healthcare Markets by Application 2001-2010
  • Table 5-14: The Potential for Epilepsy Therapeutics in the Major World Healthcare Markets 2001-2010
  • Figure 1-1: Incidence of Major Neurologic Diseases in the Major World Healthcare Markets, 2001-2010
  • Figure 1-2: The Total Market for Neurotherapeutics in the Major World Healthcare Markets, 2001-2010
  • Figure 1-3: Growth Rates in the World’s Seven Major Neurotherapeutics Markets by Application, 2001-2009
  • Figure 1-4: Growth Rates in the World’s Seven Major Neurotherapeutics Markets by Geographic Region, 2001-2009
  • Figure 1-5: Composition of the Markets for Neurotherapeutics by Applications Segment, 2002 and 2010
  • Figure 1-6: Composition of the Markets for Neurotherapeutics by Geographic Segment, 2002 and 2010
  • Figure 2-1: Structure of the Normal Motor Neuron
  • Figure 4-1: Genes Associated with Neurologic Diseases and Disorders: Chromosomes 1-4
  • Figure 4-2: Genes Associated with Neurologic Diseases and Disorders: Chromosomes 5-8
  • Figure 4-3: Genes Associated with Neurologic Diseases and Disorders: Chromosomes 9-12:
  • Figure 4-4: Genes Associated with Neurologic Diseases and Disorders: Chromosomes 13-16
  • Figure 4-5: Genes Associated with Neurologic Diseases and Disorders: Chromosomes 17-20
  • Figure 4-6: Genes Associated with Neurologic Diseases and Disorders: Chromosomes 21, 22, X, and Y
  • Figure 5-1: Growth Rates in Neurotherapeutics Potential for the Seven Major World Healthcare Markets, 2001-2010
  • Figure 5-2: Distribution of the Estimated Market Potential for Neurotherapeutics in the Seven Major World Healthcare Markets, 2002

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report